|国家科技期刊平台
| 注册
首页|期刊导航|药物分析学报（英文）|Isovalerylspiramycin Ⅰ alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2(NUBP2)-vascular non-inflammatory molecule-1(VNN1)pathway

Isovalerylspiramycin Ⅰ alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2(NUBP2)-vascular non-inflammatory molecule-1(VNN1)pathway

Na Zhang Weixiao Niu Weiping Niu Yiming Li Simin Guo Yang Li Weiqing He Hongwei He

药物分析学报（英文）2025，Vol.15Issue(3)：625-636,12.
✕
药物分析学报（英文）2025，Vol.15Issue(3)：625-636,12.DOI:10.1016/j.jpha.2024.101048

Isovalerylspiramycin Ⅰ alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2(NUBP2)-vascular non-inflammatory molecule-1(VNN1)pathway

Isovalerylspiramycin Ⅰ alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2(NUBP2)-vascular non-inflammatory molecule-1(VNN1)pathway

Na Zhang 1Weixiao Niu 2Weiping Niu 1Yiming Li 1Simin Guo 1Yang Li 1Weiqing He 3Hongwei He1

作者信息

  • 1. NHC Key Laboratory of Biotechnology for Microbial Drugs,Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100050,China
  • 2. Medical Department of Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan,250021,China
  • 3. CAMS Key Laboratory of Synthetic Biology for Drug Innovation,Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100050,China
  • 折叠

摘要

关键词

Liver fibrosis/Isovalerylspiramycin Ⅰ/Carrimycin/Nucleotide-binding protein 2/Vascular non-inflammatory molecule-1

Key words

Liver fibrosis/Isovalerylspiramycin Ⅰ/Carrimycin/Nucleotide-binding protein 2/Vascular non-inflammatory molecule-1

引用本文复制引用

Na Zhang,Weixiao Niu,Weiping Niu,Yiming Li,Simin Guo,Yang Li,Weiqing He,Hongwei He..Isovalerylspiramycin Ⅰ alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2(NUBP2)-vascular non-inflammatory molecule-1(VNN1)pathway[J].药物分析学报（英文）,2025,15(3):625-636,12.

基金项目

The study is supported by the Beijing Natural Science Founda-tion,China(Grant No.:7222118),the National Natural Science Foundation of China(Grant No.:82073900),and the CAMS Inno-vation Fund for Medical Sciences,China(CIFMS,Grant Nos.:2021-I2M-1-030,and 2021-I2M-1-028). （Grant No.:7222118）

药物分析学报（英文）

2095-1779

访问量0
|
下载量0
段落导航相关论文